PMC:7402624 / 7314-7537 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T34","span":{"begin":69,"end":75},"obj":"Body_part"}],"attributes":[{"id":"A34","pred":"fma_id","subj":"T34","obj":"http://purl.org/sig/ont/fma/fma7203"}],"text":"rs (83% of the cohort). Nearly 20% of subjects suffered from chronic kidney disease and 18% had a previous thromboembolic event. A subset of patients (18%) were immunosuppressed, and 7% and 6% of patients were known to have"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T4","span":{"begin":69,"end":75},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"}],"text":"rs (83% of the cohort). Nearly 20% of subjects suffered from chronic kidney disease and 18% had a previous thromboembolic event. A subset of patients (18%) were immunosuppressed, and 7% and 6% of patients were known to have"}

{"project":"LitCovid-PubTator","denotations":[{"id":"208","span":{"begin":141,"end":149},"obj":"Species"},{"id":"209","span":{"begin":196,"end":204},"obj":"Species"},{"id":"221","span":{"begin":61,"end":83},"obj":"Disease"},{"id":"222","span":{"begin":107,"end":121},"obj":"Disease"}],"attributes":[{"id":"A208","pred":"tao:has_database_id","subj":"208","obj":"Tax:9606"},{"id":"A209","pred":"tao:has_database_id","subj":"209","obj":"Tax:9606"},{"id":"A221","pred":"tao:has_database_id","subj":"221","obj":"MESH:D051436"},{"id":"A222","pred":"tao:has_database_id","subj":"222","obj":"MESH:D013923"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"rs (83% of the cohort). Nearly 20% of subjects suffered from chronic kidney disease and 18% had a previous thromboembolic event. A subset of patients (18%) were immunosuppressed, and 7% and 6% of patients were known to have"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T61","span":{"begin":61,"end":83},"obj":"Disease"},{"id":"T62","span":{"begin":69,"end":83},"obj":"Disease"}],"attributes":[{"id":"A61","pred":"mondo_id","subj":"T61","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A62","pred":"mondo_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/MONDO_0001343"},{"id":"A63","pred":"mondo_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/MONDO_0005240"}],"text":"rs (83% of the cohort). Nearly 20% of subjects suffered from chronic kidney disease and 18% had a previous thromboembolic event. A subset of patients (18%) were immunosuppressed, and 7% and 6% of patients were known to have"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T76","span":{"begin":69,"end":75},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T77","span":{"begin":69,"end":75},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T78","span":{"begin":69,"end":75},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T79","span":{"begin":88,"end":90},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T80","span":{"begin":96,"end":97},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T81","span":{"begin":129,"end":130},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T82","span":{"begin":151,"end":153},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"}],"text":"rs (83% of the cohort). Nearly 20% of subjects suffered from chronic kidney disease and 18% had a previous thromboembolic event. A subset of patients (18%) were immunosuppressed, and 7% and 6% of patients were known to have"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T4","span":{"begin":61,"end":83},"obj":"Phenotype"},{"id":"T5","span":{"begin":107,"end":127},"obj":"Phenotype"}],"attributes":[{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0012622"},{"id":"A5","pred":"hp_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/HP_0001907"}],"text":"rs (83% of the cohort). Nearly 20% of subjects suffered from chronic kidney disease and 18% had a previous thromboembolic event. A subset of patients (18%) were immunosuppressed, and 7% and 6% of patients were known to have"}

{"project":"LitCovid-sentences","denotations":[{"id":"T50","span":{"begin":24,"end":128},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"rs (83% of the cohort). Nearly 20% of subjects suffered from chronic kidney disease and 18% had a previous thromboembolic event. A subset of patients (18%) were immunosuppressed, and 7% and 6% of patients were known to have"}